Novo Nordisk (NVO) — #10 in Top 10 Best Stock Picks of the Decade | Top10Grid
#10
Novo Nordisk (NVO)
The Danish pharmaceutical company behind Ozempic and Wegovy rode the GLP-1 weight-loss drug wave to become Europe's most valuable company with returns exceeding 700%.
Comments on "Novo Nordisk (NVO)"
Create a free account or sign in to join the discussion.
Sign in to join the conversation